Fingerprint
Dive into the research topics of 'Imatinib mesylate therapy for polycythemia vera: Final result of a phase II study initiated in 2001'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib mesylate therapy for polycythemia vera: Final result of a phase II study initiated in 2001
Roberto H. Nussenzveig, Jorge Cortes, Matjaz Sever, Alfonso Quintás-Cardama, Pat Ault, Taghi Manshouri, Carlos Bueso-Ramos, Josef T. Prchal, Hagop Kantarjian, Srdan Verstovsek
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations